Healthy Human Volunteers Clinical Trial
Official title:
A Phase 1a, Repeat-Dose Escalation Study to Investigate the Safety and Tolerability of a 7-Day Repeated Dose of Retinoid QLT091001 in Healthy Volunteers
Healthy volunteer subjects will receive retinoid QLT091001 once-daily for 7 days for safety observation.
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04339283 -
Effect of Standardized Hibiscus Sabdariffa Tea in Seemingly Healthy Human Volunteers
|
N/A | |
Completed |
NCT00813670 -
Single and Multiple Ascending Dose Safety Study of XPF-001 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02219438 -
Continuous Adductor Canal Nerve Blocks: Relative Effects of a Basal Infusion v. Hourly Bolus Doses
|
Phase 4 |